Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides

Guangming Qin1, Yongxue Zhang, Wei Cao

  • 1Department of Nuclear Medicine, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Abstract

Insights

Radiolabelled antisense oligonucleotides successfully visualized experimental atherosclerosis in rabbits. This molecular imaging technique shows promise for early, non-invasive detection of atherosclerotic plaques.

Area of Science:

  • Molecular imaging
  • Cardiovascular research
  • Biomedical engineering

Background:

  • Atherosclerosis is a major cause of cardiovascular disease.
  • Early detection of atherosclerotic plaques is crucial for effective treatment.
  • Current imaging methods have limitations in plaque visualization.

Purpose of the Study:

  • To visualize experimental atherosclerotic lesions using radiolabeled antisense oligonucleotides (ASONs).
  • To assess the potential of ASONs for non-invasive imaging of atherosclerosis.

Main Methods:

  • Atherosclerosis was induced in rabbits by a high-cholesterol diet.
  • Technetium-99m-labeled c-myc ASONs and sense oligonucleotides were injected intravenously.
  • In vivo and ex vivo imaging of aortic specimens was performed.
  • Biodistribution of radiolabeled c-myc ASON was evaluated.

Main Results:

  • Technetium-99m-labeled c-myc ASON accumulated in atherosclerotic lesions along the artery wall.
  • Ex vivo imaging confirmed that activity accumulation corresponded to atherosclerotic lesion areas.
  • Control animals receiving sense oligonucleotides showed no positive imaging results.

Conclusions:

  • Radiolabeled ASONs can effectively visualize experimental atherosclerotic lesions.
  • This molecular imaging approach holds potential for early, non-invasive detection of atherosclerotic plaques.